Vincera Pharma (VINC)

NASDAQ
14.99
+0.22(+1.49%)
  • Volume:
    69,087
  • Bid/Ask:
    14.64/15.00
  • Day's Range:
    14.75 - 14.99

VINC Overview

Prev. Close
14.77
Day's Range
14.75-14.99
Revenue
-
Open
14.79
52 wk Range
9.95-26.75
EPS
-3.61
Volume
69,087
Market Cap
258.79M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
145,307
P/E Ratio
-
Beta
-
1-Year Change
47.7%
Shares Outstanding
17,521,075
Next Earnings Date
Dec 01, 2021
What is your sentiment on Vincera Pharma?
or
Vote to see community's results!

Vincera Pharma News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellBuyBuy
SummaryStrong SellStrong SellStrong SellNeutralBuy

Vincera Pharma Company Profile

Vincera Pharma Company Profile

Employees
28

Vincerx Pharma, Inc., formerly Vincera Pharma, Inc., is a clinical-stage life sciences company. The Company focuses on the development and oncology knowledge to advance new therapies for the treatment of cancer. The Company’s small molecule drug program includes VIP152, a clinical-stage positive transcription elongation factor beta/cyclin-dependent kinase 9 (PTEFb/CDK9) inhibitor. Its antibody-drug conjugate (ADC) platform includes VIP943 (targeting CD123) and VIP924 (targeting CXCR5), which are ADC compounds and oncology targets. The bioconjugation program also includes VIP236, which is a small molecule drug conjugate (SMDC) for solid tumors.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.